Carcinoma of the uterine cervix involving the genitourinary tract

American Journal of Surgical Pathology

Volumn 40, Issue 1, 2016, Pages 27-35

  Schwartz, Lauren E ^a   Khani, Francesca ^a   Bishop, Justin A ^a   Vang, Russell ^a   Epstein, Jonathan I ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

bladder; cervical carcinoma; cervix; genitourinary

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; GATA3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR GATA 3; TUMOR MARKER; VIRUS DNA;

ADENOCARCINOMA; ADULT; AGED; BIOPSY; BLADDER TUMOR; CELL DIFFERENTIATION; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MARYLAND; MIDDLE AGED; PAPILLOMAVIRIDAE; PATHOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; SQUAMOUS CELL CARCINOMA; TUMOR INVASION; UROTHELIUM; UTERINE CERVIX TUMOR; VIROLOGY;

ADENOCARCINOMA; ADULT; AGED; BALTIMORE; BIOMARKERS, TUMOR; BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MIDDLE AGED; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; URINARY BLADDER NEOPLASMS; UROTHELIUM; UTERINE CERVICAL NEOPLASMS;

EID: 84952629257     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000524     Document Type: Article

References (29)

1. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002; 97: 72-81
2. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55: 244-265
3. Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006; 95(suppl 1): S43-103
4. Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the United States: a 35-year population-based analysis. J Womens Health (Larchmt). 2012; 21: 1031-1037
5. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11-30
6. Massad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013; 121: 829-846
7. Koh WJ, Greer BE, Abu-Rustum NR, et al. Cervical cancer. J Natl Compr Canc Netw. 2013; 11: 320-343
8. Yavuzer D, Karadayi N, Salepci T, et al. Role of human papillomavirus in the development of urothelial carcinoma. Med Oncol. 2011; 28: 919-923
9. Alexander RE, Hu Y, Kum JB, et al. p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma. Mod Pathol. 2012; 25: 1526-1533
10. Bishop JA, Ma XJ, Wang H, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012; 36: 1874-1882
11. Higgins JP, Kaygusuz G, Wang L, et al. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol. 2007; 31: 673-680
12. Miettinen M, McCue PA, Sarlomo-Rikala M, et al. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol. 2014; 38: 13-22
13. Chang A, Amin A, Gabrielson E, et al. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol. 2012; 36: 1472-1476
14. Ellis CL, Chang AG, Cimino-Mathews A, et al. GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder. Am J Surg Pathol. 2013; 37: 1756-1760
15. Rao Q, Williamson SR, Lopez-Beltran A, et al. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers. Mod Pathol. 2013; 26: 725-732
16. Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol. 2010; 117(suppl): S5-10
17. Tenti P, Zappatore R, Romagnoli S, et al. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters. J Pathol. 1996; 178: 65-70
18. Anwar K, Naiki H, Nakakuki K, et al. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer. 1992; 70: 1967-1973
19. Aynaud O, Tranbaloc P, Orth G. Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. J Urol. 1998; 159: 86-89
20. Westenend PJ, Stoop JA, Hendriks JG. Human papillomaviruses 6/11, 16/18 and 31/33/51 are not associated with squamous cell carcinoma of the urinary bladder. BJU Int. 2001; 88: 198-201
21. Alexander RE, Williamson SR, Richey J, et al. The expression patterns of p53 and p16 and an analysis of a possible role of HPV in primary adenocarcinoma of the urinary bladder. PLoS One. 2014; 9: e95724
22. Lu QL, Lalani el N, Abel P. Human papillomavirus 16 and 18 infection is absent in urinary bladder carcinomas. Eur Urol. 1997; 31: 428-432
23. Kong CS, Balzer BL, Troxell ML, et al. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol. 2007; 31: 33-43
24. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001; 92: 276-284
25. Sano T, Oyama T, Kashiwabara K, et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Surg Pathol. 1998; 153: 1741-1748
26. Darragh TM, Colgan TJ, Thomas Cox J, et al. The Lower Anogenital Squamous Terminology Standardization project for HPV-Associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol. 2013; 32: 76-115
27. Kim SH, Joung JY, Chung J, et al. Detection of human papillomavirus infection and p16 immunohistochemistry expression in bladder cancer with squamous differentiation. PLoS One. 2014; 9: e93525
28. Alameda F, Juanpere N, Pijuan L, et al. Value of p16(INK4a) in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology. Cancer Cytopathol. 2012; 120: 276-282
29. Clark PE, Agarwal N, Biagioli MC, et al. Bladder cancer. J Natl Compr Canc Netw. 2013; 11: 446-475